• Drug development implications of the latest transporter recommendations from the FDA, EMA; PMDA and ITC• Effective clinical translation of transporter-mediated PK and DDIs• Role of biomarkers in transporter- mediated efficacy, toxicity and DDI• Absolute quantification and differential expression of drug transporters• New tools: Humanized mouse models, Pet-imaging, 3D-Models and organs-on-a-chip• Quantitative transporter proteomics in translational DMPK• Optimizing transporter-mediated and/or - limited ADME• Importance of transport polymorphisms, as well as, ethnic, sex, and disease-state differencesInvited companies and institutions:• Pfizer • H.Lundbeck • ITC • University of Copenhagen • Novartis Pharma • AstraZeneca• Janssen Pharmaceutica • Radboud University Medical Center • AbbVie • Simcyp• Leiden Academic Centre for Drug Research • Dr. Margarete Fischer-Bosch Institute• UCB Biopharma • Sanofi-Aventis • GlaxoSmithKline • Bayer PharmaPriceBronze Package 2 day conference: EUR  € 2.599,- +VATSpeakers: Dr. Annalena Ungell - Senior Director and Head of Investigative ADME, Dr. Katharina Mertsch - RandD DSAR/ Drug Disposition FF - Sanofi-Aventis Deutschland GmbH, Dr. Sibylle Neuhoff - Principal Scientist - Simcyp, Dr. Matthias Wittwer - Laboratory Head - Bayer Healthcare AG, Dr. Zhizhou Fang - Laboratory conductor Drug Metabolism and Pharmacokinetics - AbbVie Deutschland GmbH, Dr. Bente Steffensen - Faculty of Health and Medicinal Sciences - Drug Transporters in ADME - University of Copenhagen